VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
48 hedge funds and large institutions have $19.4M invested in Viracta Therapeutics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
38% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 13
80% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 10
Holders
48
Holding in Top 10
1
Calls
$7K
Puts
$3K
Top Buyers
| 1 | +$284K | |
| 2 | +$56.8K | |
| 3 | +$50.9K | |
| 4 |
B
Bailard
Foster City,
California
|
+$36.2K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$18.9K |
Top Sellers
| 1 | -$100K | |
| 2 | -$97.3K | |
| 3 | -$86.2K | |
| 4 |
Two Sigma Investments
New York
|
-$82.2K |
| 5 |
William Blair & Company
Chicago,
Illinois
|
-$75.7K |